Ivonescimab in advanced squamous non-small-cell lung cancer: can we raise the survival bar? - PubMed
4 hours ago
- #ivonescimab
- #lung-cancer
- #clinical-trial
- Ivonescimab is being evaluated for advanced squamous non-small-cell lung cancer.
- Authors report institutional funding, advisory roles, and honoraria from multiple pharmaceutical companies.
- The article questions if survival outcomes can be improved with Ivonescimab.